Madam Speaker, there is no doubt that it is the height of fiscal irresponsibility for the government to be making a decision with this kind of impact without having determined the costs.
That member knows, as I do, we are watching negotiations with Europe regarding the CETA, where we have on the table the possibility that the government could extend patent protection to pharmaceuticals which could add $2.9 billion in costs to the health care system in Canada and it has not done one lick of study to determine whether that will happen. That is the level of irresponsibility the government continues to show Canadians.